← Back to patent-cliff list
Deudomperidone
Tier C — Watch / tradeDeudomperidone
CinRx Pharma Llc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：DRD2, DRD3
Indications (approved)：糖尿病胃轻瘫, Gastroparesis
Regional status
US
Phase II
2019-09-11
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Deudomperidone?
Approved indications include: 糖尿病胃轻瘫, Gastroparesis.
When does the Deudomperidone patent expire?
No public expiry year is available for Deudomperidone yet; this page updates once verified.
How do I get a quote for Deudomperidone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-07